Legal Opinion
ALLERGAN, INC. v. Sandoz, Inc.
District Court, E.D. Texas
Decided August 22, 2011No. 4:09-cv-00097PublishedCited by 4 opinions
1Opinion of the Court
FINDINGS OF FACT AND CONCLUSIONS OF LAW
T. JOHN WARD, District Judge.
I. INTRODUCTION
This is a consolidation of four patent infringement suits brought by Plaintiff Al lergan, Inc.’s (“Allergan”) pursuant to the Hatch-Waxman Act. 1 See Drug Price Competition and Patent Term Restoration Act, which is commonly referred to as the Hatch-Waxman Act, in 1984. Pub. L. No. 98-417, 98 Stat. 1585. Defendants Sandoz, Inc. (“Sandoz”); Alcon Laboratories, Inc., Alcon Research, Ltd., Alcon, Inc., and Falcon Pharmaceuticals, Ltd. (“Alcon”); Apotex, Inc. and Apotex Corp. (“Apotex”); and Watson Laboratories,…
2Cases cited47 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- New Hampshire v. MaineSupreme Court of the United States · 2001
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Teleflex, Inc. v. Ficosa North America Corp., Fico Cables, S.A., and Ficosa North America S.A. De C.V.Court of Appeals for the Federal Circuit · 2002
42 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Allergan, Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2013
- Gierum v. Glick (In re Glick)United States Bankruptcy Court, N.D. Illinois · 2017
- Allergan Sales, LLC v. Sandoz, Inc.District Court, E.D. Texas · 2016
- Allergan, Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2013